136 views9 min read
PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease
Unlocking the potential of psychedelics, including DMT, and other tryptamines to treat the significant unmet medical needs of glaucoma patientsPartnering with world-renowned research institution brings validated drug delivery expertise in novel, controlled drug-release technologiesToronto, Ontario--(Newsfile Corp. - August 5, 2021) - Phar... Read More...